135 related articles for article (PubMed ID: 29486399)
1. Generation of induced pluripotent stem cell line, CSSi004-A (2962), from a patient diagnosed with Huntington's disease at the presymptomatic stage.
Bidollari E; Rotundo G; Ferrari D; Candido O; Bernardini L; Consoli F; De Luca A; Santimone I; Lamorte G; Ilari A; Squitieri F; Vescovi AL; Rosati J
Stem Cell Res; 2018 Apr; 28():145-148. PubMed ID: 29486399
[TBL] [Abstract][Full Text] [Related]
2. Generation of induced pluripotent stem cell line, ICGi007-A, by reprogramming peripheral blood mononuclear cells from a patient with Huntington's disease.
Grigor'eva EV; Malankhanova TB; Surumbayeva A; Minina JM; Morozov VV; Abramycheva NY; Illarioshkin SN; Malakhova AA; Zakian SM
Stem Cell Res; 2019 Jan; 34():101382. PubMed ID: 30658253
[TBL] [Abstract][Full Text] [Related]
3. Derivation of Huntington's disease-affected human embryonic stem cell lines.
Bradley CK; Scott HA; Chami O; Peura TT; Dumevska B; Schmidt U; Stojanov T
Stem Cells Dev; 2011 Mar; 20(3):495-502. PubMed ID: 20649476
[TBL] [Abstract][Full Text] [Related]
4. Cellular Models: HD Patient-Derived Pluripotent Stem Cells.
Geater C; Hernandez S; Thompson L; Mattis VB
Methods Mol Biol; 2018; 1780():41-73. PubMed ID: 29856014
[TBL] [Abstract][Full Text] [Related]
5. Generation of induced pluripotent stem cell line ICGi018-A from peripheral blood mononuclear cells of a patient with Huntington's disease.
Malakhova AA; Grigor'eva EV; Malankhanova TB; Pavlova SV; Valetdinova KR; Abramycheva NY; Vetchinova AS; Illarioshkin SN; Zakian SM
Stem Cell Res; 2020 Apr; 44():101743. PubMed ID: 32179492
[TBL] [Abstract][Full Text] [Related]
6. Generation of an induced pluripotent stem cell line from a Huntington's disease patient with a long HTT-PolyQ sequence.
Miller DC; Lisowski P; Genehr C; Wanker EE; Priller J; Prigione A; Diecke S
Stem Cell Res; 2023 Apr; 68():103056. PubMed ID: 36863131
[TBL] [Abstract][Full Text] [Related]
7. Generation of induced pluripotent stem cell line, ICGi033-A, by reprogramming peripheral blood mononuclear cells from a patient with Huntington's disease.
Grigor'eva EV; Malakhova AA; Sorogina DA; Pavlova SV; Malankhanova TB; Abramycheva NY; Klyushnikov SA; Illarioshkin SN; Zakian SM
Stem Cell Res; 2022 Aug; 63():102868. PubMed ID: 35872525
[TBL] [Abstract][Full Text] [Related]
8. Manifestation of Huntington's disease pathology in human induced pluripotent stem cell-derived neurons.
Nekrasov ED; Vigont VA; Klyushnikov SA; Lebedeva OS; Vassina EM; Bogomazova AN; Chestkov IV; Semashko TA; Kiseleva E; Suldina LA; Bobrovsky PA; Zimina OA; Ryazantseva MA; Skopin AY; Illarioshkin SN; Kaznacheyeva EV; Lagarkova MA; Kiselev SL
Mol Neurodegener; 2016 Apr; 11():27. PubMed ID: 27080129
[TBL] [Abstract][Full Text] [Related]
9. Generation of induced pluripotent stem cells from three individuals with Huntington's disease.
Miller DC; Lisowski P; Lickfett S; Mlody B; Bünning M; Genehr C; Ulrich C; Wanker EE; Diecke S; Priller J; Prigione A
Stem Cell Res; 2022 Dec; 65():102976. PubMed ID: 36434993
[TBL] [Abstract][Full Text] [Related]
10. Astrocytes generated from patient induced pluripotent stem cells recapitulate features of Huntington's disease patient cells.
Juopperi TA; Kim WR; Chiang CH; Yu H; Margolis RL; Ross CA; Ming GL; Song H
Mol Brain; 2012 May; 5():17. PubMed ID: 22613578
[TBL] [Abstract][Full Text] [Related]
11. Quantitative proteomic analysis of induced pluripotent stem cells derived from a human Huntington's disease patient.
Chae JI; Kim DW; Lee N; Jeon YJ; Jeon I; Kwon J; Kim J; Soh Y; Lee DS; Seo KS; Choi NJ; Park BC; Kang SH; Ryu J; Oh SH; Shin DA; Lee DR; Do JT; Park IH; Daley GQ; Song J
Biochem J; 2012 Sep; 446(3):359-71. PubMed ID: 22694310
[TBL] [Abstract][Full Text] [Related]
12. Induced Pluripotent Stem Cells in Huntington's Disease: Disease Modeling and the Potential for Cell-Based Therapy.
Liu L; Huang JS; Han C; Zhang GX; Xu XY; Shen Y; Li J; Jiang HY; Lin ZC; Xiong N; Wang T
Mol Neurobiol; 2016 Dec; 53(10):6698-6708. PubMed ID: 26659595
[TBL] [Abstract][Full Text] [Related]
13. Human-to-mouse prion-like propagation of mutant huntingtin protein.
Jeon I; Cicchetti F; Cisbani G; Lee S; Li E; Bae J; Lee N; Li L; Im W; Kim M; Kim HS; Oh SH; Kim TA; Ko JJ; Aubé B; Oueslati A; Kim YJ; Song J
Acta Neuropathol; 2016 Oct; 132(4):577-92. PubMed ID: 27221146
[TBL] [Abstract][Full Text] [Related]
14. Induced pluripotent stem cell lines from Huntington's disease mice undergo neuronal differentiation while showing alterations in the lysosomal pathway.
Castiglioni V; Onorati M; Rochon C; Cattaneo E
Neurobiol Dis; 2012 Apr; 46(1):30-40. PubMed ID: 22227000
[TBL] [Abstract][Full Text] [Related]
15. Generation of a human induced pluripotent stem cell (iPSC) line from a 51-year-old female with attention-deficit/hyperactivity disorder (ADHD) carrying a duplication of SLC2A3.
Jansch C; Günther K; Waider J; Ziegler GC; Forero A; Kollert S; Svirin E; Pühringer D; Kwok CK; Ullmann R; Maierhofer A; Flunkert J; Haaf T; Edenhofer F; Lesch KP
Stem Cell Res; 2018 Apr; 28():136-140. PubMed ID: 29477591
[TBL] [Abstract][Full Text] [Related]
16. The first reported generation of several induced pluripotent stem cell lines from homozygous and heterozygous Huntington's disease patients demonstrates mutation related enhanced lysosomal activity.
Camnasio S; Delli Carri A; Lombardo A; Grad I; Mariotti C; Castucci A; Rozell B; Lo Riso P; Castiglioni V; Zuccato C; Rochon C; Takashima Y; Diaferia G; Biunno I; Gellera C; Jaconi M; Smith A; Hovatta O; Naldini L; Di Donato S; Feki A; Cattaneo E
Neurobiol Dis; 2012 Apr; 46(1):41-51. PubMed ID: 22405424
[TBL] [Abstract][Full Text] [Related]
17. Generation of human embryonic stem cell line chHES-458 from abnormal embryos with HTT gene mutation.
Xie P; Sun Y; Zhou X; Chen J; Du J; Sun Y; Lu G; Lin G; Ouyang Q
Stem Cell Res; 2016 Nov; 17(3):627-629. PubMed ID: 27934595
[TBL] [Abstract][Full Text] [Related]
18. Genetic correction of Huntington's disease phenotypes in induced pluripotent stem cells.
An MC; Zhang N; Scott G; Montoro D; Wittkop T; Mooney S; Melov S; Ellerby LM
Cell Stem Cell; 2012 Aug; 11(2):253-63. PubMed ID: 22748967
[TBL] [Abstract][Full Text] [Related]
19. Induced neural stem cells as a means of treatment in Huntington's disease.
Choi KA; Hong S
Expert Opin Biol Ther; 2017 Nov; 17(11):1333-1343. PubMed ID: 28792249
[TBL] [Abstract][Full Text] [Related]
20. Generation of three human iPSC lines from patients with Huntington's disease with different CAG lengths and human control iPSC line from a healthy donor.
Latoszek E; Piechota M; Liszewska E; Hansíková H; Klempíř J; Mühlbäck A; Landwehrmeyer GB; Kuznicki J; Czeredys M
Stem Cell Res; 2022 Oct; 64():102931. PubMed ID: 36228511
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
